Pharma Pricing, Non-Profit Ties Get Increasing Scrutiny From Prosecutors
Executive Summary
Off-label marketing and kickbacks may no longer be the top targets of government healthcare fraud investigations as more companies are being hit with subpoenas for pricing information.
You may also be interested in...
Pfizer Agrees To Oversight Of Charitable Assistance Programs In DOJ Settlement
Second pharma charity kickback settlement in six months resolves claims Pfizer used charity to pay Medicare patient copays for three drugs.
Copay Kickback Enforcement Gains Momentum: United Therapeutics Settles Charges
Settlement is first involving a copay assistance program operated through Caring Voice Coalition since the HHS Office of Inspector General rescinded a safe harbor for the charity's activities in late November. Is it the first of a wave?
Price-Fixing: Steakhouse Dinner, Emails Do Not Show Conspiracy, Generic Firms Contend
Companies argue why 40 US attorneys general have no antitrust case against them in joint and individual motions to dismiss complaint.